Project Details
| Short title | HRS-5041-103 |
|---|---|
| Status | Active |
| Effective start/end date | 13/08/25 → 21/01/27 |
CTU: A Phase I, Open-label, Multi-Center, Non-Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects with Metastatic Castration-resistant Prostate Cancer
- Gurney, Howard (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Quinlan, Gabriel (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
- Garcia, Michelle (Clinical Trial Unit Staff)
- Armstrong, Emilia (Clinical Trial Unit Staff)
- Lawrie, Angus (Clinical Trial Unit Staff)
- Delahunt Smoleniec, Jacqui (Clinical Trial Unit Staff)
Project: Research